CTKB
NASDAQ · Life Sciences Tools & Services
Cytek Biosciences Inc
$4.20
+0.04 (+0.96%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,242.4% upside
Low Target
$40.67
Average Target
$56.38
High Target
$70.69
Current Price
$4.20
Current
$4.20
$4.20
Target
$56.38
$56.38
$40.67
$56.38 avg
$70.69
Scenario Analysis
Bear Case
$40.67
868.3%
Low target
Base Case
$56.38
+1,242.4%
Avg target
Bull Case
$70.69
+1,583.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.18
-32.0% from high
52-Week Low
$3.28
+28.0% from low
Target vs 52W High
$56.38
+812.3% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.09
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 36 | 81% | $369.21 | -37.8% |
| DHR | Strong Buy | 32 | 84% | $158.11 | -22.8% |
| A | Strong Buy | 29 | 76% | $64.69 | -55.7% |
| WAT | Hold | 31 | 55% | $189.60 | -53.4% |
| IQV | Strong Buy | 28 | 79% | $82.96 | -65.2% |
| ILMN | Buy | 28 | 61% | $169.36 | -9.9% |
| MTD | Hold | 19 | 47% | $170.43 | -88.1% |
| WST | Strong Buy | 23 | 91% | $136.24 | -61.5% |